Lanterne Dx is a comprehensive clinical histopathology contract research organization (CRO) and is driven by the latest in technology, methods and an expert team of PhD scientists and MD pathologists. Lanterne Dx’s facility includes a newly renovated 4500 sf CLIA-certified and CAP compliant laboratory providing services in connection with human clinical trials and validations of related activities. They consistently add to their vast library of optimized antibodies and are supported by a highly trained scientific staff. They continue to grow these teams by adding new, qualified technicians, by providing additional training, quality oversight, a healthy culture and the newest equipment available.
Lanterne Dx’s capabilities include qualitative and quantitative immunohistochemical, immunofluorescent, in situ hybridization, and microscopic applications. They deliver pre- and post-intervention analysis of clinically derived materials for diagnostics and characterization of anti-tumor efficacy endpoints. As a valuable compliment to the IHC services, Lanterne Dx also offers the latest imaging technology with Aperio AT2 high-throughput slide scanners, fluorescent whole-slide scanners and the well-respected, and versatile Visiopharm image analysis software.